{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,17]],"date-time":"2026-03-17T11:42:06Z","timestamp":1773747726469,"version":"3.50.1"},"reference-count":42,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2006,7,1]],"date-time":"2006-07-01T00:00:00Z","timestamp":1151712000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Contraception"],"published-print":{"date-parts":[[2006,7]]},"DOI":"10.1016\/j.contraception.2006.03.016","type":"journal-article","created":{"date-parts":[[2006,5,19]],"date-time":"2006-05-19T07:19:02Z","timestamp":1148023142000},"page":"48-55","source":"Crossref","is-referenced-by-count":50,"title":["Mifepristone and misoprostol sequential regimen side effects, complications and safety"],"prefix":"10.1016","volume":"74","author":[{"given":"Regine","family":"Sitruk-Ware","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.contraception.2006.03.016_bib1","series-title":"The antiprogestin steroid RU 486 and human fertility control","first-page":"123","article-title":"Toxicological study on RU 486","author":"Deraedt","year":"1985"},{"issue":"series III, no. 7","key":"10.1016\/j.contraception.2006.03.016_bib2","first-page":"281","article-title":"New data on the hormonal requirements of the pregnant rabbit: partial pregnancies and fetal abnormalities after treatment with a hormonal antagonist at subabortifacient doses","volume":"303","author":"Jost","year":"1986","journal-title":"C R Acad Sci"},{"key":"10.1016\/j.contraception.2006.03.016_bib3","series-title":"The antiprogestin steroid RU 486 and human fertility control","first-page":"87","article-title":"Biochemical profile of mifepristone","author":"Moguilewsky","year":"1985"},{"key":"10.1016\/j.contraception.2006.03.016_bib4","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1530\/jrf.0.0900255","article-title":"Effects of treatment of male and female rats in infancy with mifepristone on reproductive function in adulthood","volume":"90","author":"Vander Schoot","year":"1990","journal-title":"J Reprod Fertil"},{"key":"10.1016\/j.contraception.2006.03.016_bib5","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1210\/jcem-59-1-25","article-title":"The new steroid analog RU 486 inhibits glucocorticoid action in man","volume":"59","author":"Bertagna","year":"1984","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.contraception.2006.03.016_bib6","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1210\/jcem-61-6-1009","article-title":"RU 486 inhibits peripheral effects of glucocorticoids in humans","volume":"61","author":"Gaillard","year":"1985","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.contraception.2006.03.016_bib7","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1210\/jc.78.2.375","article-title":"Administration of RU 486 for 8 days in normal volunteers: antiglucocorticoid effect with no evidence of peripheral cortisol deprivation","volume":"78","author":"Bertagna","year":"1994","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.contraception.2006.03.016_bib8","doi-asserted-by":"crossref","first-page":"1719","DOI":"10.1016\/j.fertnstert.2005.05.056","article-title":"Management of patients receiving long-term treatment with mifepristone","volume":"84","author":"Spitz","year":"2005","journal-title":"Fertil Steril"},{"key":"10.1016\/j.contraception.2006.03.016_bib9","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1016\/0006-2952(96)00357-7","article-title":"Identification of CYP3A4 as the principal enzyme catalyzing mifepristone (RU 486) oxidation in human liver microsomes","volume":"52","author":"Jang","year":"1996","journal-title":"Biochem Pharmacol"},{"key":"10.1016\/j.contraception.2006.03.016_bib10","unstructured":"Mifeprex labeling at http:\/\/www.fda.gov\/cder\/foi\/label\/2000\/20687lbl.htm."},{"key":"10.1016\/j.contraception.2006.03.016_bib11","first-page":"241","article-title":"Approval of mifepristone (RU 486) in Europe","volume":"122","author":"Sitruk-Ware","year":"2000","journal-title":"Zentralbl Gynakol"},{"key":"10.1016\/j.contraception.2006.03.016_bib12","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1111\/j.1471-0528.1988.tb06840.x","article-title":"The effect of the antiprogestin RU 486 on uterine contractility and sensitivity to prostaglandin and oxytocin","volume":"95","author":"Swahn","year":"1988","journal-title":"Br J Obstet Gynaecol"},{"key":"10.1016\/j.contraception.2006.03.016_bib13","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/0010-7824(90)90102-2","article-title":"Mifepristone (RU 486) for cervical ripening prior to surgically induced abortion in the late first trimester","volume":"42","author":"Urquhart","year":"1990","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2006.03.016_bib14","doi-asserted-by":"crossref","first-page":"1509","DOI":"10.1056\/NEJM199305273282101","article-title":"Early termination of pregnancy with mifepristone (RU 486) and the orally active prostaglandin misoprostol","volume":"328","author":"Peyron","year":"1993","journal-title":"N Engl J Med"},{"issue":"Suppl 2","key":"10.1016\/j.contraception.2006.03.016_bib15","first-page":"85","article-title":"Termination of early pregnancy (up to and after 63 days of amenorrhea) with mifepristone (RU 486) and increasing doses of misoprostol","volume":"40","author":"Aub\u00e9ny","year":"1995","journal-title":"Int J Fertil"},{"key":"10.1016\/j.contraception.2006.03.016_bib16","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0010-7824(96)00252-1","article-title":"The efficacy and tolerance of mifepristone and prostaglandin in termination of pregnancy of less than 63 days gestation; UK multicenter study \u2014 final results","volume":"55","author":"Urquhart","year":"1997","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2006.03.016_bib17","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.1056\/NEJM199804303381801","article-title":"Early pregnancy termination with mifepristone and misoprostol in the United States","volume":"338","author":"Spitz","year":"1998","journal-title":"N Engl J Med"},{"key":"10.1016\/j.contraception.2006.03.016_bib18","doi-asserted-by":"crossref","first-page":"278","DOI":"10.3109\/00016349209021052","article-title":"Medical termination of early pregnancy with mifepristone (RU 486) followed by a prostaglandin analogue","volume":"71","author":"Ulmann","year":"1992","journal-title":"Acta Obstet Gynecol Scand"},{"key":"10.1016\/j.contraception.2006.03.016_bib19","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/j.contraception.2005.03.011","article-title":"Safety of mifepristone abortions in clinical use","volume":"72","author":"Henderson","year":"2005","journal-title":"Contraception"},{"issue":"Suppl","key":"10.1016\/j.contraception.2006.03.016_bib20","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/j.contraception.2005.03.011","article-title":"Correction: safety of mifepristone abortions in clinical use","volume":"72","author":"Henderson","year":"2005","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2006.03.016_bib21","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1016\/0140-6736(91)91593-J","article-title":"A death associated with mifepristone\/sulprostone","volume":"337","author":"Anonymous","year":"1991","journal-title":"Lancet"},{"key":"10.1016\/j.contraception.2006.03.016_bib22","unstructured":"FDA public health advisory. Sepsis and medical abortion. http:\/\/www.fda.gov\/cder\/drug\/advisory\/mifeprex.htm."},{"key":"10.1016\/j.contraception.2006.03.016_bib23","doi-asserted-by":"crossref","first-page":"1441","DOI":"10.1086\/344464","article-title":"Toxic shock syndrome due to Clostridium sordellii: a dramatic postpartum and postabortion disease","volume":"35","author":"Sinave","year":"2002","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.contraception.2006.03.016_bib24","doi-asserted-by":"crossref","first-page":"2352","DOI":"10.1056\/NEJMoa051620","article-title":"Fatal toxic shock syndrome associated to Clostridium Sordellii, after medical abortion","volume":"353","author":"Fischer","year":"2005","journal-title":"N Engl J Med"},{"key":"10.1016\/j.contraception.2006.03.016_bib25","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/S0010-7824(01)00196-2","article-title":"First trimester abortion with mifepristone and vaginal misoprostol","volume":"63","author":"Knudsen","year":"2001","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2006.03.016_bib26","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/S0010-7824(01)00200-1","article-title":"Mifepristone and misoprostol for early abortion when no gestational sac is present","volume":"63","author":"Schaff","year":"2001","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2006.03.016_bib27","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.contraception.2004.04.009","article-title":"Infection after medical abortion: a review of the literature","volume":"70","author":"Shannon","year":"2004","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2006.03.016_bib28","doi-asserted-by":"crossref","first-page":"2167","DOI":"10.1093\/oxfordjournals.humrep.a138412","article-title":"A comparison of medical abortion (using mifepristone and gemeprost) with surgical vacuum aspiration: efficacy and early medical sequelae","volume":"9","author":"Henshaw","year":"1994","journal-title":"Hum Reprod"},{"key":"10.1016\/j.contraception.2006.03.016_bib29","series-title":"A clinician's guide to medical and surgical abortion","first-page":"1693","article-title":"Abortion complications: prevention and management","author":"Lichtenberg","year":"1999"},{"key":"10.1016\/j.contraception.2006.03.016_bib30","doi-asserted-by":"crossref","first-page":"1222","DOI":"10.1111\/j.1471-0528.1996.tb09633.x","article-title":"Impact of the introduction of new medical methods on therapeutic abortions at the Royal Infirmary of Edinburgh","volume":"103","author":"Cameron","year":"1996","journal-title":"Br J Obstet Gynaecol"},{"key":"10.1016\/j.contraception.2006.03.016_bib31","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1093\/oxfordjournals.humrep.a137703","article-title":"Treatment with mifepristone (RU 486) and oestradiol facilitates the development of genital septic disease after copulation in female rats","volume":"7","author":"Van der Schoot","year":"1992","journal-title":"Human Reprod"},{"key":"10.1016\/j.contraception.2006.03.016_bib32","doi-asserted-by":"crossref","first-page":"2317","DOI":"10.1056\/NEJMp058260","article-title":"Fatal infections associated with mifepristone-induced abortions","volume":"353","author":"Greene","year":"2005","journal-title":"N Engl J Med"},{"key":"10.1016\/j.contraception.2006.03.016_bib33","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1136\/jcp.50.3.259","article-title":"A fatal postpartum Clostridium sordellii associated toxic shock syndrome","volume":"50","author":"Bitti","year":"1997","journal-title":"J Clin Pathol"},{"key":"10.1016\/j.contraception.2006.03.016_bib34","unstructured":"Fiala C. PhD thesis. Improving medical termination of pregnancy. Karolinska Institute, Stockholm, Sweden, October 2005."},{"key":"10.1016\/j.contraception.2006.03.016_bib35","doi-asserted-by":"crossref","first-page":"1483","DOI":"10.1345\/aph.1G189","article-title":"Pathophysiology of mifepristone-induced septic shock due to Clostridium sordellii","volume":"39","author":"Miech","year":"2005","journal-title":"Ann Pharmacother"},{"key":"10.1016\/j.contraception.2006.03.016_bib36","doi-asserted-by":"crossref","first-page":"1474","DOI":"10.1210\/jcem-71-6-1474","article-title":"Effect of chronic treatment with the glucocorticoid antagonist RU 486 in man: toxicity, immunological, and hormonal aspects","volume":"71","author":"Laue","year":"1990","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.contraception.2006.03.016_bib37","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/S0140-6736(05)60300-5","article-title":"Fetal malformation and failed medical termination of pregnancy","volume":"352","author":"Sitruk-Ware","year":"1998","journal-title":"Lancet"},{"key":"10.1016\/j.contraception.2006.03.016_bib38","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1016\/0140-6736(91)91490-L","article-title":"Development after exposure to mifepristone in early pregnancy","volume":"338","author":"Pons","year":"1991","journal-title":"Lancet"},{"key":"10.1016\/j.contraception.2006.03.016_bib39","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1345\/aph.1G481","article-title":"Analysis of severe adverse events related to the use of mifepristone as an abortifacient","volume":"40","author":"Gary","year":"2006","journal-title":"Ann Pharmacother"},{"key":"10.1016\/j.contraception.2006.03.016_bib40","series-title":"Reproductive medicine. A millenium review","first-page":"288","article-title":"Medical recommendations for the safe use of mifepristone","author":"Sitruk-Ware","year":"1999"},{"key":"10.1016\/j.contraception.2006.03.016_bib41","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/S0010-7824(03)00171-9","article-title":"Pharmacological properties of mifepristone toxicology and safety in animal and human studies","volume":"68","author":"Sitruk-Ware","year":"2003","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2006.03.016_bib42","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1097\/00001703-200206000-00013","article-title":"Mifepristone: contraceptive and non-contraceptive uses","volume":"14","author":"Ho","year":"2002","journal-title":"Curr Opin Obstet Gynecol"}],"container-title":["Contraception"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0010782406000965?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0010782406000965?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,4,18]],"date-time":"2019-04-18T19:03:29Z","timestamp":1555614209000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0010782406000965"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,7]]},"references-count":42,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2006,7]]}},"alternative-id":["S0010782406000965"],"URL":"https:\/\/doi.org\/10.1016\/j.contraception.2006.03.016","relation":{},"ISSN":["0010-7824"],"issn-type":[{"value":"0010-7824","type":"print"}],"subject":[],"published":{"date-parts":[[2006,7]]}}}